series-b
Stage
2
Investors
About
Maculaser develops a temperature-controlled retinal laser therapy that uses personalized heat exposure to activate natural cellular defense mechanisms for the treatment and prevention of retinal disorders.
Explore Maculaser's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.